Skip to the page

Data / Drug companies / Fermion Oy

Fermion Oy: 20 products in the FDA NDC directory, labeler code 12780

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Fermion Oy (labeler code 12780) lists 20 products in the FDA National Drug Code Directory. By type: 20 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 15, 2021.

The request: Watch Fermion Oy (FDA labeler code 12780): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
12780
Products in commercial distribution
20
Packages
20
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 1
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
November 19, 1981
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients20100%

Products by type

TypeProductsShare
Bulk ingredients20100%

Dosage forms

Dosage formProductsShare
Powder20100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Trilaciclib dihydrochloride dihydrate12780-4780PowderBulk ingredientsFebruary 15, 2021
Formoterol fumarate12780-4880PowderBulk ingredientsJanuary 12, 2016
Hydroxychloroquine sulfate12780-2771PowderBulk ingredientsJanuary 12, 2016
Carbidopa12780-4420PowderBulk ingredientsJune 28, 2011
Methotrexate sodium12780-6690PowderBulk ingredientsJanuary 14, 2010
Irinotecan hydrochloride12780-4860PowderBulk ingredientsJune 29, 2007
Quetiapine fumarate12780-4930PowderBulk ingredientsFebruary 2, 2006
Mercaptopurine12780-0299PowderBulk ingredientsJanuary 15, 2001
Glipizide12780-4680PowderBulk ingredientsDecember 4, 2000
Dexmedetomidine hydrochloride12780-4640PowderBulk ingredientsOctober 30, 1998
Azathioprine12780-0300PowderBulk ingredientsJune 27, 1997
Cromolyn sodium12780-4960PowderBulk ingredientsJanuary 1, 1997
Propafenone hydrochloride12780-4900PowderBulk ingredientsJune 29, 1995
Flutamide12780-4750PowderBulk ingredientsMay 23, 1995
Buspirone hydrochloride12780-2940PowderBulk ingredientsOctober 21, 1994
Alprazolam12780-4630PowderBulk ingredientsApril 4, 1991
Nadolol12780-0154PowderBulk ingredientsApril 4, 1986
Tolnaftate12780-4800PowderBulk ingredientsApril 3, 1985
Diltiazem hydrochloride12780-2960PowderBulk ingredientsFebruary 6, 1985
Methotrexate12780-0491PowderBulk ingredientsNovember 19, 1981

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.